Anna Sorokin, convicted swindler, is suing U.S. immigration authorities claiming she was denied a COVID-19 booster while locked up
Fake German heiress Anna Sorokin is suing U.S. immigration authorities after the convicted swindler tested positive for coronavirus, claiming she was denied a COVID-19 booster while in a suburban New York lockup.
Inon behalf of herself and three other inmates, Sorokin, 31, says she has “several medical conditions that make her vulnerable to serious illness or death from COVID-19, including a chronic kidney infection as well as depression, anxiety, and post-traumatic stress disorder,” adding that she received the one-dose Johnson & Johnson vaccine in April 2021.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Covid-19: Four more Covid-related deaths and 477 hospital casesThe total number of deaths linked to the virus reported by Stormont's Department of Health is 3,217.
Leer más »
Utah reports 461 new COVID-19 cases, 19 deathsThe Utah Department of Health reported 461 new cases of COVID-19 on Wednesday, a fraction of the number of cases reported during the omicron variant surge in January and early February.
Leer más »
'Inventing Anna' Sorokin sues over COVID boosters while in ICE custodyAnna Sorokin, a German woman convicted of posing as a wealthy heiress to scam banks, hotels and New York socialites, has sued federal immigration authorities for refusing to provide COVID-19 booster shots to her and other detainees facing deportation.
Leer más »
Anna Sorokin got COVID after ICE refused booster request: suit“Soho grifter” Anna Sorokin claims she caught COVID-19 last month after Immigration and Customs Enforcement refused to give her a booster shot.
Leer más »
Congresswoman DelBene tests positive for COVID-19DelBene says she will be isolating and working remotely and will not be attending the State of the Union address.
Leer más »
Demand for Science Lab Buildings Soars During Covid-19 PandemicThe rapid growth of life sciences research during the pandemic is triggering a record development boom for new labs and offices serving these companies
Leer más »